|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Regranex
Cardium Therapeutics: Wall Street Analyst Forum Presentation ... - May 22, 2007 Seeking Alpha,What’s unique about this is, we have a therapeutic predicator PDGF-B which is a Regranex product. Regranex, we will talk about it in a minute is a well
Panacos Reports Fourth Quarter and Full Year 2006 Financial Results - Feb 21, 2007 Business Wire (press release),His career has been highlighted by leadership roles in the development and approval of the prescription drugs LEVAQUIN, TOPAMAX, REMINYL, REGRANEX,
Panacos Appoints Alan W. Dunton, MD as New CEO - Jan 8, 2007 PharmaLive.com (press release),...approval of the prescription drugs Levaquin(R), TOPAMAX(R), Reminyl(R), Regranex(R), and Risperdal(R), as well as the successful OTC product Aleve(R).
Panacos Appoints Alan W. Dunton, MD as New CEO - Jan 8, 2007 Business Wire (press release),...highlighted by leadership roles in the development and approval of the prescription drugs Levaquin®, TOPAMAX®, Reminyl®, Regranex®, and Risperdal®,
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|